跳至主要内容
临床试验/NCT03088904
NCT03088904已完成1 期

Genetic and Environmental Factors in the Response to Influenza Vaccination

Stanford University2 个研究点 分布在 1 个国家目标入组 109 人开始时间: 2014年10月3日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
入组人数
109
试验地点
2
主要终点
Hemagglutination inhibition (HAI) titers in response to influenza vaccination.

研究概览

简要总结

The purpose of the study is to investigate and compare the immune responses to influenza vaccination in monozygotic (identical) and dizygotic (fraternal) twins to determine the roles of genetics and environment in the response to flu vaccination.

详细描述

This is a phase 1 study of 120 healthy 12-49 year old adolescents and adult volunteers who are given licensed seasonal influenza vaccine. There are no exclusions for gender, ethnicity or race. The volunteers will be enrolled into one of 3 groups:

Group A: Up to 40 healthy monozygotic (MZ) twin volunteers, 12-49 years old, will be given inactivated influenza vaccine quadrivalent (IIV4). Each volunteer will complete a total of 3 visits: Day 0 (pre-immunization), Day 6-8 and Day 28+ 7 post-immunization. All visits will consist of drawing blood for study assays and monitoring for serious adverse events (SAEs).

Group B: Up to 40 healthy dizygotic (DZ) twin volunteers, 12-49 years old, will be given inactivated influenza vaccine quadrivalent (IIV4). Each volunteer will complete a total of 3 visits: Day 0 (pre-immunization), Day 6-8 and Day 28+7 post-immunization. All visits will consist of drawing blood for study assays and monitoring for serious adverse events (SAEs).

Group C: Up to 40 healthy monozygotic (MZ) twin volunteers, 12-49 years old, will be randomized within the twin pair to receive either inactivated influenza vaccine quadrivalent (IIV4) or live, attenuated influenza vaccine quadrivalent (LAIV4). Each volunteer will complete a total of 3 visits: Day 0 (pre-immunization), Day 6-8 and Day 28+7 post-immunization. All visits will consist of drawing blood for study assays and monitoring for serious adverse events (SAEs). This group was terminated in 2016 due to ACIP recommendations against the use of LAIV but was reopened in 2018 with the availability of LAIV4.

Each twin is counted as a single participant. All reporting numbers reflect the number of participants, not the number of twin pairs.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
None

入排标准

年龄范围
12 Years 至 49 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Hemagglutination inhibition (HAI) titers in response to influenza vaccination.

时间窗: Day 0 to Day 28

Interferon-gamma (IFN-γ) production by T cells

时间窗: Day 0 to Day 28

IFN-γ production by Natural Killer (NK) cells.

时间窗: Day 0 to Day 28

次要结局

  • Sequencing of T-cell receptor (TCR)ab and Immunoglobulin Genes(Day 0 to Day 28)
  • Natural Killer (NK) repertoire.(Day 0 to Day 28)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Philip Grant

Assistant Professor of Medicine (Infectious Diseases)

Stanford University

研究点 (2)

Loading locations...

相似试验